Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment-Reference-Cited by-同舟云学术

Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment

Published:2021-08 Issue: Volume:94 Page:62-66
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

White Christine A.^ORCID,Sarabia Sam,Collier Christine P.,McCudden Christopher,Holden Rachel M.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference18 articles.

1. Clinical practice guideline update for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder;KDIGO;Kidney Int. Suppl.,2017

2. Parathyroid hormone metabolism and signaling in health and chronic kidney disease;Evenepoel;Kidney Int.,2016

3. Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values;Cavalier;Nephrol. Dial. Transplant.,2012

4. Inter-method variability in PTH measurement: implication for the care of CKD patients;Souberbielle;Kidney Int.,2006

5. Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease;Almond;Ann. Clin. Biochem.,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province;BMJ Open;2024-08

2. Preanalytical considerations in parathyroid hormone measurement;Clinica Chimica Acta;2023-01

3. Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s;Nephrology Dialysis Transplantation;2022-08-17